I agree that this site is using cookies. You can find further informations here.
X
Fisseha, Nahome
9  results:
Search for persons X
?
1

Continuous subcutaneous foslevodopa/foscarbidopa infusion f..:

Fung, Victor S.C. ; Aldred, Jason ; Arroyo, Martha P....
Clinical Parkinsonism & Related Disorders.  10 (2024)  - p. 100239 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Safety of Foslevodopa/Foscarbidopa During Optimization and ..:

Kern, Drew ; Dashtipour, Khashayar ; Aldred, Jason...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
3

Tilavonemab in early Alzheimer's disease: results from a ph..:

Florian, Hana ; Wang, Deli ; Arnold, Steven E...
Brain.  146 (2023)  6 - p. 2275-2284 , 2023
Link: https://doi.org/10.1093/..
 
?
4

Efficacy and safety of foslevodopa/foscarbidopa versus oral..:

Facheris, Maurizio ; Robieson, Weining ; Fisseha, Nahome.
Journal of the Neurological Sciences.  429 (2021)  - p. 119569 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Efficacy and Safety of Foslevodopa/Foscarbidopa Versus Oral..:

Facheris, Maurizio ; Robieson, Weining ; Fisseha, Nahome.
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
6

Identifying predictive factors of patient dropout in Alzhei..:

Crimin, Kimberly ; Allen, Patricia J ; Abba, Iman...
Alzheimer's & Dementia.  17 (2021)  S9 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
7

Baseline amyloid and tau PET imaging characteristics in the..:

Wooten, Dustin W. ; Guo, Qi ; Jin, Ziyi...
Alzheimer's & Dementia.  17 (2021)  S4 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
8

Tilavonemab in early Alzheimer's disease: results from a ph..:

Florian, Hana ; Wang, Deli ; Arnold, Steven E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232284/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

Safety and efficacy of tilavonemab in progressive supranucl..:

Höglinger, Günter U ; Litvan, Irene ; Mendonca, Nuno...
qt6bc7k734.  , 2021
Link: https://escholarship.org..
 
1-9